Rapidly progressive glomerulonephritis diagnostic study of choice

Jump to navigation Jump to search

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis diagnostic study of choice

CDC on Rapidly progressive glomerulonephritis diagnostic study of choice

Rapidly progressive glomerulonephritis diagnostic study of choice in the news

Blogs on Rapidly progressive glomerulonephritis diagnostic study of choice

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3], Amandeep Singh M.D.[4],

Ahmed Elsaiey, MBBCH [5], Nazia Fuad M.D.

Overview

Rapid diagnosis of rapidly progressive glomerulonephritis is very crucial to save kidneys function. It includes blood workup and renal biopsy.Renal biopsy will provide the definitive diagnosis about the extent of involvement. Sometimes the result can be delayed ,in such cases the emperative therapy should be started to prevent end stage renal disease.

Diagnostic study of choice

Renal biopsy:

  • Renal biopsy will provide the most accurate reslt.
  • Renal biopsy will give accurate information about the extent of the disease and therapy can be planned accordingly.
Microscopic findings of RPGN Source:By Nephron - Own work[2]
Immunoflourescence
  • In type I RPGN- diffuse and linear deposition of IgG along the GBM.
  • In ttype II RPGN- diffuse and irregular deposition of IgG and C3 in the mesangial matrix.
  • In type III RPGN- no finding.
  • Electron microscopy
  • In type I and type III, no electron dense deposits are seen.
Serologic studies

.

References

  1. Jennette JC (March 2003). "Rapidly progressive crescentic glomerulonephritis". Kidney Int. 63 (3): 1164–77. doi:10.1046/j.1523-1755.2003.00843.x. PMID 12631105.
  2. https://commons.wikimedia.org/w/index.php?curid=17591464